Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials.

Kanji Takahashi,Chui Ming Gemmy Cheung,Tomohiro Iida,Timothy Y Y Lai,Masahito Ohji,Yasuo Yanagi, Mika Kawano,Shino Ohsawa,Tomoyuki Suzuki,Aachal Kotecha,Hugh Lin,Vaibhavi Patel,Balakumar Swaminathan,Won Ki Lee

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie（2023）

Cited 1|Views15
No score
Abstract
ClinicalTrials.gov identifier: NCT03823287 (TENAYA); NCT03823300 (LUCERNE). Date of registration: January 30, 2019.
More
Translated text
Key words
Angiopoietin-2, Asia, Faricimab, Neovascular age-related macular degeneration, Vascular endothelial growth factor-A, Vascular stability
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined